Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

Kyung Taek Hong, MD, Soyoung Lee, Jaeseong Oh, Jung Yoon Choi, MD, Hee Young Shin, MD PhD, Kyung-Sang Yu, MD PhD, Hyoung Jin Kang, MD PhD

Blood (2019) 134 (Supplement_1): 3594.

https://doi.org/10.1182/blood-2019-125266

Published: 2019

Journal Articles

E2F1 Is a Biomarker of Selinexor Resistance in Relapsed/Refractory Multiple Myeloma Patients

Alessandro Lagana, PhD, Seongjee Park, Donna Edwards, Violetta Leshchenko, PhD, Marsha Crochiere, Yosef Landesman, PhD, David Melnekoff, BS,MS, Itai Beno, PhD, Deepak Perumal, PhD, Deepu Madduri, MD, Joshua Richter, Ajai Chari, MD, Hearn Jay Cho, MD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2018) 132 (Supplement 1): 3216.

https://doi.org/10.1182/blood-2018-99-116500

Published: 2018

Journal Articles

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

Blood (2018) 132 (Supplement 1): 604.

https://doi.org/10.1182/blood-2018-99-110124

Published: 2018

Journal Articles

Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial

Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD PhD, Sandra Karitzky, PhD, Silke Holtkamp, Christiane Siewert, PhD, Stefanie Pflitsch, Michael Schumm, DVM, Matthias K. Eyrich, MD, Markus Wiesneth, MD, Halvard Bonig, MD MA, Rupert Handgretinger, MD PhD

Blood (2017) 130 (Supplement 1): 214.

https://doi.org/10.1182/blood.V130.Suppl_1.214.214

Published: 2017

Journal Articles

Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays

Jo-Anne Vergilio, MD, Laurie M Gay, PhD, Lei Zhong, PhD, Mark Rosenzweig, PhD, Yakov Chudnovsky, PhD, Jie He, PhD, Michelle Nahas, PhD, Siraj M Ali, MD PhD, Sugganth Daniel, MD, Shakti Ramkissoon, MD PhD, James Suh, MD, Julia A Elvin, MD PhD, Tariq I Mughal, MD FRCP, Philip J Stephens, PhD, Vincent A Miller, MD, Rachel Erlich, PhD, Jeffrey S Ross, MD, Eric A Severson, MD PhD MMSc, Samantha Morley, PhD

Blood (2017) 130 (Supplement 1): 417.

https://doi.org/10.1182/blood.V130.Suppl_1.417.417

Published: 2017

Journal Articles

Determination of Red Blood Cell Alloimmunization Rates in Transfused Patients with Hematologic and Oncologic Malignancies

Mariette Asare, MD, Jeanne E Hendrickson, MD, Christopher A Tormey, MD

Blood (2016) 128 (22): 1463.

https://doi.org/10.1182/blood.V128.22.1463.1463

Published: 2016

Journal Articles

TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/II Clinical Trial

Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD, Sandra Karitzky, PhD, Silke Holtkamp, PhD, Christiane Siewert, PhD, Michael Schumm, VMD, Matthias K. Eyrich, MD, Markus Wiesneth, Halvard Bönig, MD, Rupert Handgretinger, MD

Blood (2016) 128 (22): 389.

https://doi.org/10.1182/blood.V128.22.389.389

Published: 2016

Journal Articles

Palliative Outpatient Care in Children with Hematologic Malignancies Compared to Solid Tumors

Michaela Kuhlen, MD, Jessica I Hoell, MD, Gabriele Gagnon, MD, Stefan Balzer, MD, Arndt Borkhardt, MD, Gisela Janßen, MD

Blood (2016) 128 (22): 5977.

https://doi.org/10.1182/blood.V128.22.5977.5977

Published: 2016

Journal Articles

Bleeding in Patients Receiving Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis

Chatree Chai-Adisaksopha, MD, Matthew Cheah, Said Y. ALKindi, MD ARCPath, Alfonso Iorio, MD PhD, Mark A. Crowther, MD MSc, FRCPC, Lori Ann Linkins, MD MSc, FRCPC

Blood (2015) 126 (23): 1120.

https://doi.org/10.1182/blood.V126.23.1120.1120

Published: 2015

Journal Articles

Novel Evidence That Neuroblastoma and Rhabdomyosarcoma, Two Types of Small Round Blue Cell Tumors, Frequently Infiltrate Bone Marrow and Express Functional Erythropoietin Receptor (EpoR)—therapeutic Implications

Agata Poniewierska-Baran, MS, Gabriela Schneider, PhD, Janina Ratajczak, MD PhD, Magdalena Kucia, PhD, Mariusz Z Ratajczak, MD PhD

Blood (2014) 124 (21): 4019.

https://doi.org/10.1182/blood.V124.21.4019.4019

Published: 2014

Journal Articles

Young Paternal Age and Risk Of Infant Acute Lymphoblastic Leukemia

Julie A Ross, PhD, Todd E Druley, MD, PhD, Kimberly J Johnson, Rachel K. Fonstad, M.S., Julie von Behren, MPH, Beth Mueller, PhD, Susan Carozza, PhD, Eric J. Chow, MD, MPH, Colleen McLaughlin, PhD, Peggy Reynolds, PhD, Erin Fox, PhD, Scott Horel, Logan G. Spector, PhD

Blood (2013) 122 (21): 1395.

https://doi.org/10.1182/blood.V122.21.1395.1395

Published: 2013

Journal Articles

Hematopoietic Stem Cell Transplantation and Secondary Primary Malignancies in Taiwan

Chia-Jen Liu, MD, Kuo-Wei Chen, MD, Yu-Wen Hu, MD, Ying-Chung Hong, MD, Yu-Chung Huang, MD, Tzeon-Jye Chiou, MD, Cheng-Hwai Tzeng, MD

Blood (2012) 120 (21): 4219.

https://doi.org/10.1182/blood.V120.21.4219.4219

Published: 2012

Journal Articles

Romiplostim in a Case Series of Chemotherapy-Induced Thrombocytopenia

Rekha Parameswaran, MD, Gerald A. Soff, MD

Blood (2011) 118 (21): 1170.

https://doi.org/10.1182/blood.V118.21.1170.1170

Published: 2011

Journal Articles

Incidence of Secondary Neoplasms In Patients with Acute Promyelocytic Leukemia Treated with All-Trans-Retinoic Acid (ATRA) with Chemotherapy or with Arsenic Trioxide (ATO).

Alireza Eghtedar, MD, Stefan Faderl, MD, Hagop Kantarjian, MD, Susan O'Brien, MD, Guillermo Garcia-Manero, MD, Alessandra Ferrajoli, MD, Tapan Kadia, MD, Sherry A. Pierce, RN, BS, Jenny Shan, PhD, Jorge E. Cortes, MD, Farhad Ravandi, MD

Blood (2010) 116 (21): 1085.

https://doi.org/10.1182/blood.V116.21.1085.1085

Published: 2010

Journal Articles

TET Family Oncogene Fus Is Essential for the Maintenance of Self-Renewing Hematopoietic Stem Cells.

Takeaki Sugawara, MD, PhD, Hideyuki Oguro, PhD, Atsushi Iwama, MD, PhD

Blood (2009) 114 (22): 2529.

https://doi.org/10.1182/blood.V114.22.2529.2529

Published: 2009

Journal Articles

Novel Pleiotropic Effects of Thrombin in Regulation of Metastatic Potential of Human Rhabdomyosarcoma (RMS) Cells – Identification of Negative PAR1 and PAR3 Receptor Crosstalk.

Marcin Wysoczynski, PhD, Rui Liu, M.D., Mariusz Z Ratajczak, MD, PhD

Blood (2009) 114 (22): 336.

https://doi.org/10.1182/blood.V114.22.336.336

Published: 2009

Journal Articles

Novel Pleiotropic Effects of Thrombin in Regulation of the Metastatic Potential of Human Rhabdomyosarcoma (RMS) Cells.

Marcin Wysoczynski, MS, Mariusz Z Ratajczak, M.D., Ph.D.

Blood (2008) 112 (11): 2270.

https://doi.org/10.1182/blood.V112.11.2270.2270

Published: 2008

Journal Articles

An in Vitro and in Vivo Evidence That Human Rhabdomyosarcomas (RMS) Express Functional CXCR7 Receptor: Overlapping and Distinct Role of CXCR4-SDF-1 and CXCR7-SDF-1/ITAC Axes in Regulating Metastatic Behavior of RMS Cells

Kasia Grymula, Ph.D., Maciek Tarnowski, Ph.D., Radoslaw Maksym, Magdalena Kucia, Ph.D., Janina Ratajczak, M.D., Ph.D., Mariusz Z Ratajczak, M.D., Ph.D.

Blood (2008) 112 (11): 4732.

https://doi.org/10.1182/blood.V112.11.4732.4732

Published: 2008

Journal Articles

Mesenchymal Stem Cell Differentiation Markers Shared with Soft Tissue Sarcomas

Stefan Wirths, Hans-Joerg Buehring, Lothar Kanz, Joerg T Hartmann, Hans-Georg Kopp

Blood (2008) 112 (11): 4755.

https://doi.org/10.1182/blood.V112.11.4755.4755

Published: 2008

Journal Articles

Expression of CXCR4 and CXCR7 Receptors for Stromal Derived Factor-1 (SDF- 1) Is Differently Regulated in Human Rhabdomyosarcomas (RMS): The Biological Consequences

Maciek Tarnowski, Ph.D., Radoslaw Maksym, Ryan Reca, Ph.D., Mariusz Z Ratajczak, M.D., Ph.D., Magdalena Kucia, Ph.D.

Blood (2008) 112 (11): 4764.

https://doi.org/10.1182/blood.V112.11.4764.4764

Published: 2008

NARROW

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

E2F1 Is a Biomarker of Selinexor Resistance in Relapsed/Refractory Multiple Myeloma Patients

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial

Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays

Determination of Red Blood Cell Alloimmunization Rates in Transfused Patients with Hematologic and Oncologic Malignancies

TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/II Clinical Trial

Palliative Outpatient Care in Children with Hematologic Malignancies Compared to Solid Tumors

Bleeding in Patients Receiving Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis

Novel Evidence That Neuroblastoma and Rhabdomyosarcoma, Two Types of Small Round Blue Cell Tumors, Frequently Infiltrate Bone Marrow and Express Functional Erythropoietin Receptor (EpoR)—therapeutic Implications

Young Paternal Age and Risk Of Infant Acute Lymphoblastic Leukemia

Hematopoietic Stem Cell Transplantation and Secondary Primary Malignancies in Taiwan

Romiplostim in a Case Series of Chemotherapy-Induced Thrombocytopenia

Incidence of Secondary Neoplasms In Patients with Acute Promyelocytic Leukemia Treated with All-Trans-Retinoic Acid (ATRA) with Chemotherapy or with Arsenic Trioxide (ATO).

TET Family Oncogene Fus Is Essential for the Maintenance of Self-Renewing Hematopoietic Stem Cells.

Novel Pleiotropic Effects of Thrombin in Regulation of Metastatic Potential of Human Rhabdomyosarcoma (RMS) Cells – Identification of Negative PAR1 and PAR3 Receptor Crosstalk.

Novel Pleiotropic Effects of Thrombin in Regulation of the Metastatic Potential of Human Rhabdomyosarcoma (RMS) Cells.

An in Vitro and in Vivo Evidence That Human Rhabdomyosarcomas (RMS) Express Functional CXCR7 Receptor: Overlapping and Distinct Role of CXCR4-SDF-1 and CXCR7-SDF-1/ITAC Axes in Regulating Metastatic Behavior of RMS Cells

Mesenchymal Stem Cell Differentiation Markers Shared with Soft Tissue Sarcomas

Expression of CXCR4 and CXCR7 Receptors for Stromal Derived Factor-1 (SDF- 1) Is Differently Regulated in Human Rhabdomyosarcomas (RMS): The Biological Consequences

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only